Onward Therapeutics SA
Epalinges, Vaud, Switzerland · Biotechnology, Health Care, Medical
Onward Therapeutics SA is a clinical stage oncology company focused on developing innovative therapies for cancer treatment. With a commitment to advancing onco-metabolism programs, they aim to identify and develop promising compounds for effective cancer care. The company's research efforts are geared towards translating scientific discoveries into breakthrough therapeutic solutions.
Key facts
- Headquarters
- Epalinges, Vaud, Switzerland
- Employees
- 10
- Industries
- Biotechnology, Health Care, Medical
- Status
- Private
- Website
- onward-therapeutics.com
- Company page
Recent activity at Onward Therapeutics SA
- : Onward Therapeutics closes NT$900M (US$28M) Series B financing to advance oncology pipeline. The round includes new investors and supports clinical programs in Taiwan.
- : Onward Therapeutics Enters Worldwide License Agreement with Institut du Cancer de Montpellier for Onco-Metabolism Program. (date Fundz recorded it)
Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.
Onward Therapeutics SA funding history
| Date | Round | Amount |
|---|---|---|
| Nov 2026 | Series B | $28.0M |
Onward Therapeutics SA in the news
Companies similar to Onward Therapeutics SA
- Swarm Oncology Ltd · Biotechnology, Health Care, Medical, research, Therapeutics
- Faeth Therapeutics · Biotechnology, Health Care, Medical, research, Therapeutics
- Aptose Biosciences · Biotechnology, Health Care, Medical, research, Therapeutics
- Celldex · Biotechnology, Health Care, Medical, research, Therapeutics
- Genentech · Biotechnology, Health Care, Medical, research, Therapeutics
About Onward Therapeutics SA: questions and answers
What does Onward Therapeutics SA do?
Onward Therapeutics SA is a clinical stage oncology company focused on developing innovative therapies for cancer treatment. With a commitment to advancing onco-metabolism programs, they aim to identify and develop promising compounds for effective cancer care. The company's research efforts are geared towards translating scientific discoveries into breakthrough therapeutic solutions.
Where is Onward Therapeutics SA headquartered?
Onward Therapeutics SA is headquartered in Epalinges, Vaud, Switzerland.
How many employees does Onward Therapeutics SA have?
Onward Therapeutics SA has about 10 employees.
Has Onward Therapeutics SA raised funding?
Yes. Fundz has recorded 1 funding event for Onward Therapeutics SA. The most recent, Series B of $28.0M, was in Nov 2026.
What is the latest news on Onward Therapeutics SA?
On Nov 17, 2026, Onward Therapeutics closes NT$900M (US$28M) Series B financing to advance oncology pipeline. The round includes new investors and supports clinical programs in Taiwan.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy